- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01240330
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
Evaluation of the Effect of the Vasculaire Compression System on Flow Velocity in the Femoral Vein
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Venous thromboembolism, e.g. deep vein thrombosis (DVT) and pulmonary embolism, occurs in approximately one in 1,000 persons in the United States annually and results in more than 250,000 hospital admissions annually in the United States. Intermittent pneumatic compression (IPC), which prevents stasis in the lower limbs, has been shown to be a safe and effective method of prophylaxis of DVT in studies comparing the incidence of DVT and pulmonary embolism with and without IPC. IPC devices decrease venous stasis by augmenting the venous blood flow in the lower extremities. Studies have suggested that an important indicator of the effectiveness of an IPC device in preventing DVT is the peak femoral venous velocity augmentation during the compression phase as compared with the decompression phase of the device.
IPC devices produced in the early 1980s and 1990s were cumbersome, noisy and required external power sources, making them suitable only for non-ambulatory patients. Furthermore, these devices have been associated with poor compliance in trauma patients in a hospital setting, and the poor compliance was associated with a higher rate of DVT.
The aim of this study is to test the hemodynamic performance of a new portable IPC device, the Venous Health Systems' Vasculaire Compression System. This new device is designed to provide patient comfort and convenience of use while providing similar improvement in venous blood flow when compared with existing IPC devices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Portola Valley, California, United States, 94028
- Venous Health System, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female subjects between 18 years old and 65 years old;
- Capable of and willing to lay supine for approximately one hour;
- Subjects must provide written informed consent
Exclusion Criteria:
- History of Deep Vein Thrombosis (DVT) or suspected DVT;
- History of vascular disease, e.g. coronary or peripheral artery disease;
- History of stroke;
- History of pulmonary edema;
- History of congestive heart failure;
- Diabetes mellitus;
- Past or present smoker;
- Surgery or trauma to the right leg within the last six months;
- Open ulcers or wounds on the right leg;
- Pregnant or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Femoral Venous Peak Flow Velocity Compared to Resting Baseline
Time Frame: 3 measurements/10 min. therapy
|
The femoral vein in the mid-thigh area was located and the femoral venous Peak Flow Velocity (PFV)was measured using duplex ultrasound during the compression phase of treatment.
PFV is the maximum velocity of blood flow achieved when the foot and calf compression is applied.
The PFV was then compared to the subject's own baseline PFV using a paired t-test.
|
3 measurements/10 min. therapy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PFV Percent Augmentation
Time Frame: 3 measurements/10 minute therapy
|
Peak Flow Velocity (PFV) from the compression phase subtracted from the PFV from the decompression phase divided by the PFV from the decompression phase expressed as the percent augmentation.
|
3 measurements/10 minute therapy
|
Subject Comfort
Time Frame: 10 min therapy
|
Subject comfort was measured on a scale 1 to 5 (1=negative response; 5=positive response) during the sleeve installation, during use, and completion.
|
10 min therapy
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas J Fogarty, M.D., founder
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VenousHealth-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Thrombosis
-
Hospital de Clinicas de Porto AlegreCompletedDeep Venous Thromboses | Deep Venous Thrombosis of Left Leg | Deep Venous Thrombosis of Right Leg | Deep Venous Thrombosis Proximal
-
Merit Medical Systems, Inc.CompletedChronic Venous Thrombosis | Venous Thrombosis Upper Extremity | Venous Thrombosis Upper Extremity Superficial VeinsAustria, Germany, Italy
-
Intermountain Health Care, Inc.TerminatedDeep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous ThrombosisUnited States
-
Policlinico HospitalCompletedCentral Venous Catheter Thrombosis | Intensive Care Unit | Thrombosis, Venous | Central Venous CathetersItaly
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompletedVenous Thrombosis (Disorder)United States
-
University of Roma La SapienzaUnknownVenous Thromboembolism | Deep Venous ThrombosisItaly
-
The First Affiliated Hospital of Guangzhou Medical...CompletedDeep Venous Thrombosis
-
Russian Phlebological AssociationRecruitingVenous Insufficiency | Varicose Veins of Lower Limb | Thromboses, VenousRussian Federation
-
Tong ZhuNot yet recruitingDeep Vein Thrombosis | Deep Venous Insufficiency
-
Maastricht University Medical CenterTerminatedRandomized Clinical Trial | Deep-Venous Thrombosis | Deep Venous StentingNetherlands
Clinical Trials on Pneumatic Compression therapy
-
badri jaafariCompleted
-
Karolinska University HospitalEnrolling by invitationHealing Wound | Venous Stasis | Deep Venous ThrombosisSweden
-
King Abdullah International Medical Research CenterUnity Health Toronto; Mount Sinai Hospital, Canada; King Fahad Medical City; Royal... and other collaboratorsCompletedDeep Venous ThrombosisSaudi Arabia
-
Walter Reed National Military Medical CenterWithdrawnEkbom Syndrome | Restless Legs Syndrome, | Restless Legs,United States
-
University of California, San DiegoCompletedHealthy | DiabetesUnited States
-
Tactile MedicalCompletedLower Extremity Lymphoedema | Leg LymphoedemaUnited Kingdom
-
Hospital for Special Surgery, New YorkDJO IncorporatedCompletedTotal Hip ArthroplastyUnited States
-
University of CalgaryCompleted
-
Feng TianActive, not recruitingApplication of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.Stomach Neoplasms | Gastrointestinal Neoplasms | Intestinal NeoplasmsChina